Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Medpace Holdings, Inc. (MEDP) vs Mettler-Toledo International, Inc. (MTD)

Medpace Holdings, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $30.4B against $17.3B — 1.8× the size. Mettler-Toledo International, Inc. trades at the lower P/E: 33.9× against 35.6×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 17.7%) and the higher return on invested capital (35.4% vs 0.00%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 15 and Mettler-Toledo International, Inc. on 7.

Valuation

Metric MEDP MTD Diagnostics & Research median
P/E 35.59 33.94 33.95
P/S 6.27 7.36 4.87
P/B 40.19 2,372.01 3.12
Price to free cash flow 24.67 35.21 34.02
EV/EBITDA 27.97 24.88 25.20
EV/Sales 6.14 7.86 5.66
Earnings yield 2.81% 2.95% (1.75%)
Free cash flow yield 4.05% 2.84% (0.13%)

Profitability

Metric MEDP MTD Diagnostics & Research median
Gross margin 72.35% 60.26% 50.89%
Operating margin 20.97% 28.41% (8.57%)
Net margin 17.67% 21.91% (6.37%)
Free cash flow margin 25.40% 20.90% 0.00%
Return on equity 162.15% (736.36%) (2.92%)
Return on assets 27.09% 25.61% (6.71%)
Return on invested capital 0.00% 35.40% 0.00%

Growth

Metric MEDP MTD Diagnostics & Research median
Revenue growth (TTM) 24.67% 6.91% 7.69%
EPS growth (last fiscal year) 20.98% 3.88% —
Revenue growth, 5-year CAGR 22.27% 5.47% 7.40%
Net income growth, 5-year CAGR 25.50% 7.60% 0.00%

Health

Metric MEDP MTD Diagnostics & Research median
Debt to equity 0.00 164.70 0.11
Current ratio 0.73 1.12 2.02
Net debt to EBITDA (0.88) 1.68 0.78

Dividend

Metric MEDP MTD Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MEDP MTD Diagnostics & Research median
Market cap 17.32b 30.44b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack